Nonspecific Antistreptolysin Reactions and Serum (or Pleural-Exudate) Cholesterol.
作者信息
Packalén T
机构信息
Tuberculosis Department, St. Göran's Hospital, Stockholm.
出版信息
J Bacteriol. 1948 Aug;56(2):143-56.
Abstract
摘要
相似文献
1
Nonspecific Antistreptolysin Reactions and Serum (or Pleural-Exudate) Cholesterol.
J Bacteriol. 1948 Aug;56(2):143-56.
2
Nonspecific antistreptolysin reactions and serum (or pleural-exudate) cholesterol.
J Bacteriol. 1948 Aug;56(2):143-56. doi: 10.1128/JB.56.2.143-156.1948.
3
Non-specific antistreptolysin reactions and serum or pleural-exudate cholesterol.
Acta Pathol Microbiol Scand. 1948;25(1-2):259-63.
4
Rheumatoid pleural effusion.
Semin Arthritis Rheum. 2006 Jun;35(6):368-78. doi: 10.1016/j.semarthrit.2006.03.002.
5
Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
Ann Clin Biochem. 2007 May;44(Pt 3):264-72. doi: 10.1258/000456307780480918.
6
[Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
Pol Merkur Lekarski. 2009 Mar;26(153):194-7.
7
Diagnostic approach to pleural effusion in adults.
Am Fam Physician. 2006 Apr 1;73(7):1211-20.
8
Peritoneal penetration of doripenem after intravenous administration in abdominal-surgery patients.
J Antimicrob Chemother. 2007 Dec;60(6):1395-7. doi: 10.1093/jac/dkm371. Epub 2007 Sep 19.
9
Bayesian analysis using continuous likelihood ratios for identifying pleural exudates.
Respir Med. 2006 Nov;100(11):1960-5. doi: 10.1016/j.rmed.2006.02.025. Epub 2006 Apr 12.
10
Use of multidimensional data analysis for prediction of lung malignity.
J Pharm Biomed Anal. 2009 Sep 8;50(2):210-5. doi: 10.1016/j.jpba.2009.04.018. Epub 2009 Apr 23.
引用本文的文献
1
The nature of antistreptolysin S in the sera of man and of other species; the lipoprotein properties of antistreptolysin S.
Br J Exp Pathol. 1949 Oct;30(5):365-75.
2
[Research on the significance of single lipoid and protein fractions of the serum as streptolysin inhibitors. II. Results of preparatory electrophoretic research].
Klin Wochenschr. 1961 Sep 15;39:949-51. doi: 10.1007/BF01482651.
3
The release of cholesterol esters from serum lipoproteins by extracts of certain group A streptococci.
J Exp Med. 1961 Nov 1;114(5):807-23. doi: 10.1084/jem.114.5.807.
4
[On the specificity of Staphylococcus alpha-antitoxin determination].
Klin Wochenschr. 1960 Oct 15;38:1065-6. doi: 10.1007/BF01482438.
5
The analysis of streptococcal infections. V. Cardiotoxicity of streptolysin O for rabbits in vivo.
J Exp Med. 1961 Apr 1;113(4):759-84. doi: 10.1084/jem.113.4.759.
6
[Studies on antistreptolysin titer in blood of mothers, newborn and young infants].
Klin Wochenschr. 1957 Sep 15;35(18):924-9. doi: 10.1007/BF01484278.
7
The use of hemolysin inhibition in the study of experimental and clinical hyperlipemia; the non-specific inhibition of streptolysin O, by serum lipoproteins.
J Clin Invest. 1954 Sep;33(9):1233-41. doi: 10.1172/JCI102998.
8
Studies on antistreptolysin O activity generated in serum by microorganisms.
Br J Exp Pathol. 1976 Feb;57(1):105-13.
本文引用的文献
1
Purification and properties of a haemolysin produced by group A haemolytic streptococci (streptolysin O).
Biochem J. 1941 Nov;35(10-11):1124-39. doi: 10.1042/bj0351124.
2
A simple colorimetric method for the estimation of haemolysis and its application to the study of streptolysin.
Biochem J. 1941 Nov;35(10-11):1116-23. doi: 10.1042/bj0351116.
3
Pneumococcal Hemolysin: The Preparation of Concentrates, and Their Action on Red Cells.
J Bacteriol. 1942 May;43(5):607-27. doi: 10.1128/jb.43.5.607-627.1942.
Zotero 插件